Skip to Content

GG 705 (Ranitidine 150 mg)

Pill with imprint GG 705 is Pink, Round and has been identified as Ranitidine hydrochloride 150 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Ranitidine is used in the treatment of gerd; erosive esophagitis; duodenal ulcer; gastric ulcer maintenance treatment; zollinger-ellison syndrome (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for GG 705

Ranitidine hydrochloride

Imprint:
GG 705
Strength:
150 mg
Color:
Pink
Size:
8.00 mm
Shape:
Round
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Pharmaceuticals Inc.
Inactive Ingredients:
D&C Red No. 30
hydroxypropyl cellulose
hypromellose 2910 (3 mPa.s)
magnesium stearate
microcrystalline cellulose
peppermint
sodium starch glycolate type A potato
titanium dioxide
triethyl citrate
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
51079-0879 UDL Laboratories Inc
66267-0188 Nucare Pharmaceuticals Inc (repackager)

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide